Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Natural Product Based Drug Discovery Against Human Parasites -

Natural Product Based Drug Discovery Against Human Parasites

Opportunities and Challenges
Buch | Softcover
XIX, 596 Seiten
2024
Springer Singapore (Verlag)
978-981-19-9607-8 (ISBN)
CHF 369,95 inkl. MwSt
  • Noch nicht erschienen - erscheint am 19.12.2024
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

Chapter 1. Recent advances on the discovery of plants derived bioactive scaffolds/extracts against parasitic diseases.- Chapter 2. Applications of Computational Methods in Natural Products based Drug Discovery.- Chapter 3. Natural Product-Based Drug Designing for treatment of Human parasitic diseases.- Chapter 4. Secondary Metabolites of Plant Origin in Parasitic manifestations.- Chapter 5. Exploring marine biodiversity as alternative resources for treatment of Human Parasitic Diseases.- Chapter 6. Marine Bioprospecting for the Treatment of Human Parasitic Diseases.- Chapter 7. Microorganisms-Derived Biochemicals: Potential Drugs for Human Parasitic Diseases.- Chapter 8. Plant-Based Vaccines against Human Parasitic Diseases.- Chapter 9. Nanotechnology: its usages in drug delivery for the treatment of Human Parasitic Diseases.- Chapter 10. Therapeutic Potential Of Benzopyrones Against Antiparasitic Diseases.- Chapter 11. Antimicrobial peptides (AMPs): current state and future prospectsfor the treatment of human parasitic diseases.- Chapter 12. Pathway To Register Natural Product-Derived Therapeutics.- Chapter 13. Recent Advances in the Treatment of Parasitic Diseases: Current Status and Future.- Chapter 14. Strategies and challenges for developing plant-based therapeutics against Protozoans.- Chapter 15. Recent approaches to combat toxoplasma gondii with plant-derived alternatives.- Chapter 16. Target-based rational improvement strategies and pitfalls in Leishmania drug discovery.- Chapter 17. Versatile Structurally Diverse Natural Products and Their Semisynthetic Analogs as Potential Anti-leishmanial Drugs.- Chapter 18. Promising compounds of plant origin and their synthetic analogs against Trypanosomes.- Chapter 19. Pathogenesis and Immune Response inT. cruzi infection: Quest for Natural compound-based drugs.- Chapter 20. Limitations of current drugs and prospects of plant-based compounds and their constructed analogues as therapeutics for treatment of malaria.- Chapter 21. An Analytical Approach to Progression in Malaria Therapeutics.- Chapter 22. Malaria Drug Discovery: How to tackle the problem of Drug Resistance.- Chapter 23. Approaches to drug discovery against Ascariasis: Opportunity and challenges in plant-based products.- Chapter 24. The Potential of Plant Secondary Metabolites as Drugs or Leads Against Helminths.- Chapter 25. Drug Resistance in Helminth parasites: Role of plant based natural therapeutics.- Chapter 26. Schistosomiasis: current and future strategies to develop novel therapeutics.

Erscheinungsdatum
Zusatzinfo XIX, 596 p. 1 illus.
Verlagsort Singapore
Sprache englisch
Maße 155 x 235 mm
Themenwelt Naturwissenschaften Biologie Mikrobiologie / Immunologie
Schlagworte Drug-resistance • Host-pathogen interactions • nanotechnology • Parasitic Infection • Treatment Strategies
ISBN-10 981-19-9607-5 / 9811996075
ISBN-13 978-981-19-9607-8 / 9789811996078
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Allgemeine Grundlagen und spezielle Anwendungen

von Gerhard Gstraunthaler; Toni Lindl

Buch | Softcover (2021)
Springer Berlin (Verlag)
CHF 76,95